Journal article Impact of Lipid Bilayer Composition and Physicochemical Properties on Constitution of a Transmembrane Helical Peptide into Exosome-Mimetic Vesicles
Shiho Tsutsumi (author) (Search by this author)
ORCID ;
Yuki Takechi-Haraya (author) (Search by this author)
ORCID ;
Yasuhiro Abe (author) (Search by this author)
ORCID ; ORCID SAMURAI
Collection

Citation
Shiho Tsutsumi, Yuki Takechi-Haraya, Yasuhiro Abe, Kohsaku Kawakami. Impact of Lipid Bilayer Composition and Physicochemical Properties on Constitution of a Transmembrane Helical Peptide into Exosome-Mimetic Vesicles. Molecular Pharmaceutics. 2025, 22 (11), 6874-6886. https://doi.org/10.1021/acs.molpharmaceut.5c00825

Description:

(abstract)

Exosomes are expected to efficiently deliver drugs, such as microRNAs and proteins, to targeted organs. However, using natural exosomes presents many difficulties in terms of safety, quality control, and manufacturing; therefore, developing exosome-mimetic artificial materials is desirable. In this study, we elucidated how sphingomyelin (SM) and cholesterol (CH), the
main constituents of the exosome membrane, in addition to phosphatidylcholine (PC), influence the physicochemical properties of PC vesicles. Then, the relevance of these properties to the secondary structure and insertion efficiency of a helical peptide, the transmembrane domain of integrin α, was investigated. The constitution of this peptide was most successful with exosome-mimetic vesicles (EMV) bearing 15 mol % SM and 40 mol % CH, and the exclusion of SM or CH resulted in low dispersion stability or
unsuccessful peptide constitution. Physicochemical analysis of the membrane properties revealed that successful peptide incorporation into the lipid membrane relied on the membrane softness induced by CH and the appearance of a highly mobile boundary phase induced by SM, which together created a favorable environment for the peptide. These results provide important insights that serve as a foundation for developing EMV as drug carriers.

Rights:

Keyword: Exosomes, Exosome mimetic vesicles, lipid membrane, helical peptide

Date published: 2025-11-03

Publisher: American Chemical Society (ACS)

Journal:

  • Molecular Pharmaceutics (ISSN: 15438384) vol. 22 issue. 11 p. 6874-6886

Funding:

  • Japan Society for the Promotion of Science JP23K06092

Manuscript type: Publisher's version (Version of record)

MDR DOI:

First published URL: https://doi.org/10.1021/acs.molpharmaceut.5c00825

Related item:

Other identifier(s):

Contact agent:

Updated at: 2025-11-25 12:30:04 +0900

Published on MDR: 2025-11-25 12:23:32 +0900

Filename Size
Filename 2025MolPharm_EMV.pdf (Thumbnail)
application/pdf
Size 4.42 MB Detail